ProQR Therapeutics N.V.
PRQR
$2.26
$0.052.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.82M | -10.61M | -9.92M | -8.91M | -2.90M |
| Total Depreciation and Amortization | 766.10K | 713.50K | 715.30K | 756.40K | 765.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.45M | 341.00K | -182.30K | 710.20K | 364.90K |
| Change in Net Operating Assets | -1.34M | -7.07M | -578.80K | 1.23M | -4.97M |
| Cash from Operations | -12.94M | -16.63M | -9.96M | -6.22M | -6.73M |
| Capital Expenditure | -114.60K | -235.70K | -141.80K | -314.40K | -287.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -2.83M | 18.69M | -- |
| Cash from Investing | -114.60K | -235.70K | -2.97M | 18.38M | -287.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -293.00K | -567.00K | -253.00K | -454.00K | -294.00K |
| Issuance of Common Stock | -- | 67.00K | 71.68M | 1.00K | 12.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -332.50K | -526.20K | 76.14M | -498.00K | -303.50K |
| Foreign Exchange rate Adjustments | -969.20K | -496.70K | 760.00K | -190.20K | 66.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.36M | -17.88M | 63.97M | 11.47M | -7.26M |